全文获取类型
收费全文 | 811篇 |
免费 | 46篇 |
国内免费 | 114篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 37篇 |
妇产科学 | 51篇 |
基础医学 | 86篇 |
口腔科学 | 10篇 |
临床医学 | 149篇 |
内科学 | 184篇 |
皮肤病学 | 26篇 |
神经病学 | 18篇 |
特种医学 | 101篇 |
外科学 | 51篇 |
综合类 | 55篇 |
预防医学 | 38篇 |
眼科学 | 15篇 |
药学 | 89篇 |
中国医学 | 5篇 |
肿瘤学 | 52篇 |
出版年
2020年 | 9篇 |
2019年 | 9篇 |
2018年 | 11篇 |
2017年 | 9篇 |
2016年 | 11篇 |
2015年 | 23篇 |
2014年 | 31篇 |
2013年 | 54篇 |
2012年 | 38篇 |
2011年 | 36篇 |
2010年 | 37篇 |
2009年 | 41篇 |
2008年 | 15篇 |
2007年 | 85篇 |
2006年 | 38篇 |
2005年 | 26篇 |
2004年 | 13篇 |
2003年 | 11篇 |
2002年 | 13篇 |
2001年 | 18篇 |
2000年 | 13篇 |
1999年 | 14篇 |
1998年 | 40篇 |
1997年 | 31篇 |
1996年 | 30篇 |
1995年 | 26篇 |
1994年 | 26篇 |
1993年 | 18篇 |
1992年 | 10篇 |
1991年 | 13篇 |
1990年 | 21篇 |
1989年 | 21篇 |
1988年 | 30篇 |
1987年 | 13篇 |
1986年 | 5篇 |
1985年 | 12篇 |
1984年 | 6篇 |
1983年 | 6篇 |
1982年 | 8篇 |
1981年 | 11篇 |
1980年 | 8篇 |
1979年 | 8篇 |
1978年 | 6篇 |
1977年 | 8篇 |
1976年 | 5篇 |
1975年 | 5篇 |
1971年 | 4篇 |
1970年 | 4篇 |
1958年 | 14篇 |
1955年 | 4篇 |
排序方式: 共有971条查询结果,搜索用时 15 毫秒
61.
62.
据文献记载和作者的调查,我国产麻黄属(Ephedra)植物共有13种3变种1变型。本文报道我国北方生产的7种麻黄生药形态组织学比较研究结果。7种麻黄是:草麻黄Ephedra sinica Stapf、木贼麻黄E.equisetina Bunge、中麻黄E.intermedia Schrenk ex Mey.、膜果麻黄E.przewalskii Stapf,单子麻黄E.monosperma Gmel.ex Mey.、雌雄麻黄E.fedtschenkoae Pauls和细子麻黄E.reaeliana Florin。文中附有生药性状与组织构造特征比较表及生药组织图 相似文献
63.
64.
Daniel TP Fong Mak-Ham Lam Miko LM Lao Chad WN Chan Patrick SH Yung Kwai-Yau Fung Pauline PY Lui Kai-Ming Chan 《Journal of orthopaedic surgery and research》2008,3(1):7
Background
Excessive pronation (or eversion) at ankle joint in heel-toe running correlated with lower extremity overuse injuries. Orthotics and inserts are often prescribed to limit the pronation range to tackle the problem. Previous studies revealed that the effect is product-specific. This study investigated the effect of medial arch-heel support in inserts on reducing ankle eversion in standing, walking and running. 相似文献65.
66.
67.
Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects. 总被引:11,自引:0,他引:11
Theodore P Ciaraldi Alice P S Kong Neelima V Chu Dennis D Kim Sunita Baxi Mattias Loviscach Ray Plodkowski Richard Reitz Michael Caulfield Sunder Mudaliar Robert R Henry 《Diabetes》2002,51(1):30-36
Type 2 diabetic subjects failing glyburide therapy were randomized to receive additional therapy with either metformin (2,550 mg/day) or troglitazone (600 mg/day) for 3-4 months. Biopsies of subcutaneous abdominal adipose tissue were obtained before and after therapy. Glycemic control was similar with both treatments. Metformin treatment increased insulin-stimulated whole-body glucose disposal rates by 20% (P < 0.05); the response to troglitazone was greater (44% increase, P < 0.01 vs. baseline, P < 0.05 vs. metformin). Troglitazone-treated subjects displayed a tendency toward weight gain (5 +/- 2 kg, P < 0.05), increased adipocyte size, and increased serum leptin levels. Metformin-treated subjects were weight-stable, with unchanged leptin levels and reduced adipocyte size (to 84 +/- 4% of control, P < 0.005). Glucose transport in isolated adipocytes from metformin-treated subjects was unaltered from pretreatment. Glucose transport in both the absence (321 +/- 134% of pre-Rx, P < 0.05) and presence of insulin (418 +/- 161%, P < 0.05) was elevated after troglitazone treatment. Metformin treatment had no effect on adipocyte content of GLUT1 or GLUT4 proteins. After troglitazone treatment, GLUT4 protein expression was increased twofold (202 +/- 42%, P < 0.05). Insulin-stimulated serine phosphorylation of Akt was augmented after troglitazone (170 +/- 34% of pre-Rx response, P < 0.05) treatment and unchanged by metformin. We conclude that the ability of troglitazone to upregulate adipocyte glucose transport, GLUT4 expression, and insulin signaling can contribute to its greater effect on whole-body glucose disposal. 相似文献
68.
69.
Serum levels of lipid associated sialic acid (LASA), mucoid proteins (MP) and hexoses (galactose + mannose) were measured in 41 breast cancer patients, 14 patients with benign breast diseases and 36 healthy age matched female individuals. In breast carcinoma patients, we have observed significant increase in the levels of the three markers compared with the controls (P less than 0.001) and in MP and hexoses compared to the patients with benign breast diseases (P less than 0.001). LASA and hexoses levels were significantly higher in benign breast diseases with respect to controls (P less than 0.001 and P less than 0.01, respectively). We evaluated the sensitivity and specificity of the markers individually and in combination. MP were most sensitive (71.8%) and specific (71.4%). Both sensitivity and specificity were increased when combinations of the markers were studied. Combination of MP with LASA was most sensitive (97.4%) while the combination of MP and hexoses was most specific (92.9%). LASA was significantly elevated in infiltrating duct carcinoma compared to lobular carcinoma (P less than 0.001). MP and hexoses also showed higher mean value in infiltrating duct carcinoma than lobular carcinoma. The present study suggests that the combination of the markers investigated might be useful for diagnosis and classification of breast carcinoma. 相似文献
70.